Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy (FOX)

Conditions: Duchenne Muscular Dystrophy Interventions: Drug: EDG-5506 Dose 1; Drug: EDG-5506 Dose 2; Drug: Placebo Sponsors: Edgewise Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials